It showed higher AUC, sensitivity, and specificity (0.872, 85.19, and 82.61, respectively) than AFP (0.695, 62.96, and 60.87, respectively) in predicting the prognosis of patients with HCC. This evidence concerns the gene AFP and hepatocellular carcinoma.